Lopinavir/Ritonavir (Kaletra) PK in Children

Completed · Phase 4

Conditions studied: HIV/AIDS Treatment, HIV Infections

In brief

The objective of this study is to compare the pharmacokinetics of lopinavir tablets administered to pediatric patients as either whole or crushed tablets. The study is a randomized,open-label, crossover study of pediatric subjects already taking lopinavir/ritonavir tablets as part of their clinical care. THe investigators hypothesize that lopinavir exposure in pediatric patients will be lower after taking a dose of the tablet formulation, crushed and mixed with pudding or yogurt, as compared to the exposure after taking a dose with tablets swallowed whole.

Key facts

Study ID
NCT00810108
Run by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
People needed
12
Starts
2006-06-01
Expected to finish
2009-05-01
Last updated by the study team
2012-07-06

Who can join

Age: 6 and older, up to 17. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.